$3.12 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 4 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGRY | SURGERY PARTNERS INC | $1,703,761,283 | -35.0% | 58,248,249 | 0.0% | 54.55% | +38.8% | |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $1,314,160,084 | -31.3% | 60,199,729 | 0.0% | 42.08% | +46.6% | |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | $97,105,047 | -29.6% | 81,600,880 | 0.0% | 3.11% | +50.3% | |
| ADV | ADVANTAGE SOLUTIONS INC | $8,207,600 | +21.4% | 2,890,000 | 0.0% | 0.26% | +160.4% | |
| DSEY | Exit | DIVERSEY HLDGS LTD | $0 | – | -236,983,211 | -100.0% | -29.82% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners XII, LLC #1
- Bain Capital Fund XII, L.P. #2
- BCPE Perception GP, LLC #3
- BC Perception Holdings, LP #4
- Bain Capital Partners XI, L.P. #5
- Bain Capital Fund XI, L.P. #6
- BCPE Eagle GP, LLC #7
- BCPE Diamond GP, LLC #8
- BCPE Eagle Investor, LP #9
- BCPE Diamond Investor, LP #10
- BCPE Seminole GP LLC #11
- BCPE Seminole Holdings LP #12
- BCPE Seminole Holdings IV, L.P. #13
- BCPE Seminole GP II LLC #14
- BCPE Seminole GP III LLC #15
- BCPE Seminole Holdings II Intermediate LP #16
- BCPE Seminole Holdings III, L.P. #17
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-21 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-18 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-06 |
| 4 | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.